SWP Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Buy
2,857
+100
+4% +$102K 2.37% 14
2026
Q1
$2.54M Buy
2,757
+50
+2% +$50.7K 1.89% 27
2025
Q4
$2.91M Sell
2,707
-98
-3% -$93.7K 2.11% 20
2025
Q3
$2.14M Buy
2,805
+231
+9% +$172K 2.1% 21
2025
Q2
$2.01M Buy
2,574
+682
+36% +$530K 2.37% 12
2025
Q1
$1.56M Buy
+1,892
New +$1.57M 1.95% 27

Other funds holding LLY

SWP Investment Management's LLY Position: Q2 2026 in Review

SWP Investment Management increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $102K and bringing the position to 2,857 shares worth $3.43M. The position accounts for 2.37% of the portfolio, ranked #14.

SWP Investment Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SWP Investment Management held 2,857 shares of Eli Lilly worth $3.43M as of Q2 2026.
  • SWP Investment Management bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 2.37% of SWP Investment Management's portfolio in Q2 2026, its #14 holding.
  • SWP Investment Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SWP Investment Management's 13F filing for Q2 2026, filed 2 Jul 2026.